News early in last week was dominated by presentations at the American Society of Hematology (ASH) meeting. Among these was ...

The European Medicines Agency’s (EMA) human medicines committee (CHMP) adopted positive opinions for six biosimilar medicines ...

PwC forecasts a significant increase in pharma and biotech mergers and acquisitions in 2025, driven by regulatory changes ...

US drugmaker AbbVie is to acquire Nimble Therapeutics, a USA-based Roche spinout developing oral peptide treatments in the ...

ICER reports $815 million in unsupported price hikes among top US drugs, identifying five with unjustified increases. The ...

The European Medicines Agency’s (EMA) human medicines committee (CHMP) recommended another batch medicines for approval at ...

The US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to tolebrutinib for the treatment of ...

Poland-based drug developer Ryvu Therapeutics, a clinical-stage drug discovery biotech, yesterday provided an update on ...

Nine months out from landing $35 million in seed funding, Relation has more news – a big pharma collaboration. The group has ...

Spanish plasma-based medicines producer Grifols has announced the execution of an agreement for a private placement of 1.3 ...

Italy-based CNS specialist Newron Pharmaceuticals has entered into a license agreement with EA Pharma, part of Japan’s Eisai, ...

Canada-headquartered Bausch + Lomb Corporation, a leading global eye health company, on Thursday confirmed reports that it is ...